Acalculous Cholecystitis Market Outlook Size, Drugs, Epidemiology Trends And Forecast To 2035

(MENAFN- IMARC Group) According to the IMARC Group, the acalculous cholecystitis market reached a value of USD 359.7 Million in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 964.1 Million by 2035, exhibiting a growth rate (CAGR) of 9.41% during 2025-2035. This can be attributed to the emerging acceptance of laparoscopic cholecystectomy due to its several advantages over open surgery procedures, including less scarring, faster healing, and shorter hospital stays.

Acalculous cholecystitis (AC) is a medical condition of acute gallbladder inflammation and distention without any evidence of gallstones or cystic duct obstruction. The acalculous cholecystitis market is experiencing significant growth, driven by several key factors. Primarily, the rising incidence of acalculous cholecystitis, particularly among critically ill patients, is an important market driver. Consequently, there is an increasing need for efficient treatments and interventions in intensive care units. Additionally, advancements in diagnostic techniques, such as improved imaging technologies, have facilitated the early detection and accurate diagnosis of acalculous cholecystitis. This has led to timely and appropriate medical interventions, further boosting market acceleration.

Moreover, the growing consciousness among healthcare professionals about the critical need to identify and treat acalculous cholecystitis promptly is contributing to the market's expansion. Meanwhile, the development of novel therapeutic options, including minimally invasive procedures and targeted therapies, is propelling the acalculous cholecystitis market forward. Furthermore, the increasing prevalence of risk factors such as diabetes, cardiovascular diseases, and prolonged fasting, which are associated with a greater likelihood of developing acalculous cholecystitis, is another significant growth driver. In addition, ongoing R&D efforts aimed at understanding the pathophysiology of acalculous cholecystitis and discovering new therapeutic targets are expected to create lucrative opportunities in the market. Consequently, the convergence of these factors is expected to propel the growth of the acalculous cholecystitis market in the coming years.

Acalculous Cholecystitis Market Report provides a detailed analysis of the current marketed drugs and late-stage pipeline drugs.

In-Market Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Drug Uptake and Market Performance

Get your Sample of Acalculous Cholecystitis Market Insights for Free https://www.imarcgroup.com/acalculous-cholecystitis-market/requestsample

Most influential companies in the Acalculous Cholecystitis Market:

The market has been studied in the report with the detailed profiles of the key players operating in the market.

Countries Covered

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email:

Tel No:(D) +91 120 433 0800

United States: +1 201971-6302

MENAFN01082025004122016232ID1109871806